Read this on GERN - stem cells are HOTGeron's Study OK Signals Progress For Co, Stem Cell PeersLast update: 1/23/2009 1:09:18 PM
We view this as a significant achievement for Geron and believe it will prove to be a major catalyst to stem cell research," said Lazard Capital Markets analyst Joel Sendak. Geron shares recently rose $2.72, or 52%, to $7.93 on heavy volume. Other stem cell-related companies are getting a boost, too, including Stemcells Inc. (STEM) shares up 54 cents, or 25%, to $2.69, Neuralstem Inc. (CUR) up 17 cents, or 12%, to $1.60 and Aastrom>>